Summary by Futu AI
CVS Health Corporation officer Prem S Shah is set to sell 29,473 shares of common stock on 02/16/2024, with an aggregate market value of $2,267,923.77. The shares to be sold were acquired through various means, including Dividend Reinvestment Plans (DRIP), Employee Stock Purchase Plans, and restricted stock vesting under registered plans, with acquisition dates ranging from 2020 to 2024. The transactions involved both cash payments and services rendered as forms of payment. This planned sale follows a period where no securities were sold in the past three months, as per the latest available data.